Form4insider filings, from the source

SEC Form 4 · accession 0001962926-26-000005

Structure Therapeutics Inc. · GPCR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Xichen Lin
Officer — CHIEF SCIENTIFIC OFFICER
Period of report
Jun 25, 2026
Accepted (ET)
Jun 29, 2026 · 8:32 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001888886

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF1Jun 25, 2026M23,634$0.34A252,594D
Ordinary SharesF2Jun 25, 2026C23,634$0.00D228,960D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Share Option (right to buy)F4,F1,F3$0.34Jun 25, 2026M23,634D—Sep 10, 2029Ordinary Shares23,634190,166D
American Depositary SharesF6,F5—Jun 25, 2026C7,878A——Ordinary Shares23,6347,878D
American Depositary SharesF8,F5—Jun 25, 2026S7,878D——Ordinary Shares23,6340D

Explanation of responses